Media Inquiries
For general media inquiries, please contact media@hhs.gov.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Thanks to the Biden-Harris Administration’s whole-of-government approach to combatting COVID-19, we are now in a better place in our response than at any point of the pandemic. However, we need to continue to support the development of a new generation of tools to stay ahead of COVID-19.
An initial investment of $5 billion, collectively referred to as Project NextGen, will accelerate and streamline the rapid development of the next generation of vaccines and treatments through public-private collaborations.
Based at the U.S. Department of Health and Human Services (HHS) and led by the Administration for Strategic Preparedness and Response (ASPR’s) Biomedical Advanced Research and Development Authority (BARDA) and the National Institutes of Health (NIH’s) National Institute of Allergy and Infectious Diseases (NIAID), Project NextGen will coordinate across the federal government and the private sector to advance the pipeline of new, innovative vaccines and therapeutics into clinical trials and potential review by the U.S. Food and Drug Administration (FDA) for authorization or approval, and commercial availability for the American people.
The program will focus on several areas, including:
Announced on April 10, the program has already started the activities necessary to bring next generation vaccines and treatments to Americans, including but not limited to:
Building on experiences from HHS’s COVID-19 response efforts over the past 3-plus years, the Biden-Harris Administration will continue to address the ongoing threat of COVID-19 and to protect us against future epidemics from this same family of viruses.
View BARDA’s latest Request for Information (RFI), Areas of Interest under BARDA’s Broad Agency Announcement (BAA), and easy broad agency announcement (EZ-BAA) at:
https://sam.gov/opp/53668acd172e4440a096362247bcea73/view
https://sam.gov/opp/6f989eb9c421422788a4c3a9133917f0/view
https://sam.gov/opp/348098a7c3b741c48d93a7dbe19bbd1a/view
Receive the latest updates from the Secretary, Blogs, and News Releases
For general media inquiries, please contact media@hhs.gov.